MedTrace Logo

PREVELLE Shape (CX002) Dermal Filler Protocol

NCT00764257 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2011-12-20

No results posted yet for this study

Summary

The purpose of this study was to assess PREVELLE Shape (CX002), with respect to safety and efficacy for one year following treatment, for correction of facial nasolabial folds and when applied as an intradermal implant for lip augmentation.

Conditions

  • Correction of Nasolabial Folds and Lip Augmentation

Interventions

DEVICE

PREVELLE Shape

DEVICE

Restylane

Sponsors & Collaborators

  • Mentor Worldwide, LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2007-01-31
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00764257 on ClinicalTrials.gov